NEW MJ NEWS

AbbVie to Host First-Quarter 2023 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2023 financial results on Thursday, April 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2023-earnings-conference-call-301788964.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

PotNetwork Holding Inc. (POTN) Strengthens Advisory Board with the Appointment of Distinguished Medical Marijuana Certified Physician

PotNetwork Holding Inc. Strengthens Advisory Board with the Appointment of Distinguished Medical…

Green Thumb Industries Inc. (GTBIF) Announces Changes to Board of Directors

Green Thumb Industries Announces Changes to Board of Directors Green Thumb Industries…

$GRNH First in a Series of Greenhouses That Offer Flexible Designs

Greengro Introduces First in a Series of Greenhouses That Offer Flexible Designs,…

Tetra Bio Pharma Inc. (TBPMF) Appoints Sylvain Chrétien as President

Tetra Bio-Pharma Appoints Sylvain Chrétien as President Tetra Bio Pharma Inc. (“Tetra”…